SRPTSarepta TherapeuticsHealth Care
$17.85EarningsNov 4, 2026
1D—1W—1M—3M—1Y—
Market cap$1.9BCompany infoRevenue$2.0B52-wk range$15 – $24IndustryBiotechnologyWebsitesarepta.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▼ −5.2% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S1.0×8183
1
12
P / FCF———
EV / EBITDA———
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin58.6%6749
59%
88%
Operating margin-7.3%48
-81%
11%
Net margin-6.9%715
-114%
12%
ROE-10.0%717
-179%
21%
ROIC-4.8%511
-28%
7%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.555757
0.6
4.0
Net debt / EBITDA———
Current ratio4.429185
Interest coverage-2.5×59
Per shareTTM, with year-over-year change
Revenue / share$18.73▼ −20%
EPS (diluted)$-2.90▼ −230%
FCF / share$-1.25▲ +71%
Est. EPS growth (fwd)—